-
-
-
-
-
-
-
Prothena authorizes $100 million share repurchase program
-
-
-
-
-
-
-
Prothena Reports Second Quarter 2025 Financial Results and Business Highlights
-
-
-
-
-
-
-
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
-
-
-
-
-
-
-
Prothena Announces Achievement of $40 Million Clinical Milestone Payment from Novo Nordisk for PRX004/NNC6019 Under Investigation for the Treatment of ATTR Cardiomyopathy
-
-
-
-
-
-
-
Prothena Reports Third Quarter 2021 Financial Results and Business Highlights
-
-
-
-
-
-
-
Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion
-
-
-
-
-
-
-
After-Hours Stock Movers 10/20: (ASTC) (SNAP) (PRTA) Higher; (NAVI) (NFLX) (APTX) Lower (more...)
-
1,177,147 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

